Seizert Capital Partners, LLC Meridian Bioscience Inc Transaction History

Seizert Capital Partners, LLC

  • $2.16 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022
BUY
$17.46 - $21.61 $366,450 - $453,550
20,988 New
20,988 $428,000
Q1 2020

May 05, 2020
SELL
$5.57 - $11.5 $376,983 - $778,331
-67,681 Closed
0 $0
Q4 2019

Feb 10, 2020
BUY
$7.9 - $10.14 $210,542 - $270,241
26,651 Added 64.95%
67,681 $661,000
Q3 2019

Nov 07, 2019
BUY
$9.17 - $12.01 $376,245 - $492,770
41,030 New
41,030 $389,000

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Seizert Capital Partners, LLC Portfolio

Follow Seizert Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seizert Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email